Key result
Incorporating home blood pressure measurement into the diagnostic process for newly detected hypertension reduced estimated medical costs from US$10.89 million to US$9.33 million per 1000 subjects over 5 years.
Why the study?
Does home blood pressure measurement reduce medical costs compared to clinic blood pressure measurement in newly detected hypertensive subjects?
Does home blood pressure measurement reduce medical costs compared to clinic blood pressure measurement in newly detected hypertensive subjects?
Absolute Event Rate: 9.33% vs 10.89%
The introduction of home blood pressure measurement for diagnosing and treating hypertension is projected to significantly reduce medical costs in Japan.
No takes yet. Share an insight, caveat, or question.
Suggests home BP monitoring may yield substantial health system savings; leaves open whether these.
Fukunaga et al. (2008) studied Office hypertension. Home blood pressure (HBP) measurement vs. Casual clinic blood pressure (CBP) measurement was evaluated on Medical cost per 1000 subjects per 5 years (in million US$). Incorporating home blood pressure measurement into the diagnostic process for newly detected hypertension reduced estimated medical costs from US$10.89 million to US$9.33 million per 1000 subjects over 5 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: